4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
LEOCLAN Co.,Ltd. (7681) operates in the Medical Distribution industry and is headquartered in Settsu, Japan with about 155 employees. Its market capitalization is roughly JPY 6 billion. In the fiscal year ended 2025-09-30, 7681 reported JPY 21.5B in revenue and JPY 153M in net income.
LEOCLAN Co.,Ltd. operates as a medical equipment trading company that meets various medical care, welfare, and health needs. It operates through three segments: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business.
Interactive charts & full statements →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | JPY 21.5B | JPY 19.8B | JPY 26.6B | JPY 29.8B | — |
| Gross Profit | JPY 2.7B | JPY 2.6B | JPY 2.8B | JPY 3.1B | — |
| Operating Income (EBIT) | JPY 288M | JPY 178M | JPY 440M | JPY 651M | — |
| Net Income | JPY 153M | JPY 136M | JPY 271M | JPY 437M | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 98M) | (JPY 98M) | (JPY 98M) | (JPY 78M) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | JPY 10.9B | JPY 10.7B | JPY 14.7B | JPY 13.5B | — |
| Total Liabilities | JPY 5.0B | JPY 4.9B | JPY 9.0B | JPY 7.9B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 7681 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms